Showing 1 - 20 results of 5,672 for search '"Early breast cancer"', query time: 1.37s Refine Results
1
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer

Authors: Sonja B. Vliek, Florentine S. Hilbers, Agnes Jager, Valesca P. Retèl, Jolien M. Bueno de Mesquita, Caroline A. Drukker, Sanne C. Veltkamp, Anneke M. Zeillemaker, Emiel J. Rutgers, Harm van Tinteren, Wim H. van Harten, Laura J. van 't Veer, Marc J. van de Vijver, Sabine C. Linn

Contributors: Medical Oncology, Health Technology Assessment (HTA), Pathology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers

Source: European Journal of Cancer, 175, 169-179. Elsevier Ltd.
European Journal of Cancer, 175, 169-179. Elsevier Limited

Subject Terms: 70-gene signature, ER-positive, Early breast cancer, Gene expression profile, HER2-negative, MammaPrint, Node-negative, Observational, Prognostic, Prospective, SDG 3 - Good Health and Well-being, Cancer Research, Oncology

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d7edd507887970d9814de1ccbf3990d
http://www.scopus.com/inward/record.url?scp=85138040656&partnerID=8YFLogxK

2
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer

Authors: C. Louwrens Braal, Justin D. Westenberg, Sanne M. Buijs, Steven Abrams, Tessa A. M. Mulder, Ron H. N. van Schaik, Stijn L. W. Koolen, Agnes Jager, Ron H. J. Mathijssen

Contributors: Braal, C. Louwrens/0000-0003-3600-9851, van Schaik, Ron H. N., Koolen, Stijn L. W., Mathijssen, Ron H. J., Westenberg, Justin D., Jager, Agnes, Mulder, Tessa A. M., Braal, C. Louwrens, Buijs, Sanne M., ABRAMS, Steven, Medical Oncology, Surgery, Clinical Chemistry

Source: Breast cancer research and treatment
Breast Cancer Research and Treatment, 195(1):195, 65-74. Springer New York

Subject Terms: SDG 3 - Good Health and Well-being, Tamoxifen, Endoxifen, Early breast cancer, Predictive modeling, Therapeutic drug monitoring, Human medicine, Cancer Research, Oncology

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b1ec86ba8b860d344d13b1ebcc6226
https://doi.org/10.1007/s10549-022-06643-y

HTML Full Text     PDF Full Text
3
Lung Restriction in Patients With Breast Cancer After Hypofractionated and Conventional Radiation Therapy: A 10-Year Follow-up

Authors: Sylvia Verbanck, Hilde Van Parijs, Daniel Schuermans, Vincent Vinh-Hung, Guy Storme, Christel Fontaine, Mark De Ridder, Dirk Verellen, Eef Vanderhelst, Shane Hanon

Contributors: Clinical sciences, Pneumology, Radiation Therapy, Translational Radiation Oncology and Physics, Vriendenkring VUB, Medical Oncology, Laboratory of Molecular and Medical Oncology, Physiotherapy, Human Physiology and Anatomy, Faculty of Medicine and Pharmacy

Source: International journal of radiation oncology, biology, physics

Subject Terms: Cancer Research, Radiology, Nuclear Medicine and imaging, Oncology, Radiation, Human medicine, diffusing capacity, early breast cancer, long term follow up, RADIOTHERAPY, restriction, Pulmonary and Respiratory Medicine, surgery, respiratory system, respiratory tract diseases

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e13217bb7361f91181584cb45c29f5
https://doi.org/10.1016/j.ijrobp.2022.02.021

4
Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial

Authors: Richard D. Gelber, Xin V. Wang, Bernard F. Cole, David Cameron, Fatima Cardoso, Vivianne Tjan-Heijnen, Ian Krop, Sherene Loi, Roberto Salgado, Astrid Kiermaier, Elizabeth Frank, Debora Fumagalli, Carmela Caballero, Evandro de Azambuja, Marion Procter, Emma Clark, Eleonora Restuccia, Sarah Heeson, Jose Bines, Sibylle Loibl, Martine Piccart-Gebhart

Source: 2022, ' Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial ', European Journal of Cancer, vol. 166, pp. 219-228 . https://doi.org/10.1016/j.ejca.2022.01.031

Subject Terms: Cancer Research, Oncology, Adjuvant therapy, HER2-positive early breast cancer, Pertuzumab, STEPP (Subpopulation Treatment Effect Pattern Plot), TILs (tumour infiltrating lymphocytes), Trastuzumab

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ea7784312d3198e47cc5b66a1e3df0
https://doi.org/10.1016/j.ejca.2022.01.031

5
Oncobiology and treatment of breast cancer in young women

Authors: Kumar, Rakesh, Marques, Catarina, Toi, Masakazu, Saini, Sunil, Casimiro, Sandra, Arora, Anshika, Paul, Aswathy Mary, Velaga, Ravi, Rameshwar, Pranela, Lipton, Allan, Gupta, Sudeep, Costa, Luis

Contributors: Repositório da Universidade de Lisboa

Source: Cancer and Metastasis Reviews. 41:749-770

Subject Terms: Cancer Research, Oncology, Early breast cancer, Pathobiology, Polygenic, Prognosis, Therapeutics, Transcriptomics, Young women

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de58805c0c83c0e50f456ed97f546b01
https://doi.org/10.1007/s10555-022-10034-6

HTML Full Text     PDF Full Text
6
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis

Authors: Francesco Iovino, Anna Diana, Francesca Carlino, Franca Ferraraccio, Giuliano Antoniol, Francesca Fisone, Alessandra Perrone, Federica Zito Marino, Iacopo Panarese, Madhura S. Tathode, Michele Caraglia, Gianluca Gatta, Roberto Ruggiero, Simona Parisi, Ferdinando De Vita, Fortunato Ciardiello, Ludovico Docimo, Michele Orditura

Source: Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 6987

Subject Terms: biomarkers, early breast cancer, hepatocyte growth factor receptor, c-MET, General Medicine

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd97121266bb5f991d0432e653dc0107

HTML Full Text     PDF Full Text
7
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients

Authors: Kathleen Schüler, Daniel Bethmann, Sandy Kaufhold, Carolin Hartung, Kathrin Stückrath, Tilmann Lantzsch, Christoph Uleer, Volker Hanf, Susanne Peschel, Jutta John, Marleen Pöhler, Jörg Buchmann, Karl-Friedrich Bürrig, Edith Weigert, Christoph Thomssen, Eva Johanna Kantelhardt, Martina Vetter

Source: Diagnostics; Volume 12; Issue 10; Pages: 2527

Subject Terms: tumor infiltrating lymphocytes, early breast cancer, prognosis, cohort study, Clinical Biochemistry

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ca91060fb3cdfd51ed64486edbabf6

HTML Full Text     PDF Full Text
8
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

Authors: Sandra M. Swain, Harrison Macharia, Javier Cortes, Chau Dang, Luca Gianni, Sara A. Hurvitz, Christian Jackisch, Andreas Schneeweiss, Dennis Slamon, Pinuccia Valagussa, Yolande du Toit, Dominik Heinzmann, Adam Knott, Chunyan Song, Patricia Cortazar

Contributors: Institut Català de la Salut, [Swain SM] Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, USA. [Macharia H] F. Hoffmann-La Roche Ltd., Basel, Switzerland. [Cortes J] Quirónsalud Group, IOB Institute of Oncology, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Dang C] Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA. [Gianni L] Fondazione Michelangelo, Milano, Italy. [Hurvitz SA] David Geffen School of Medicine, University of California, Los Angeles, USA, Vall d'Hebron Barcelona Hospital Campus

Source: Cancers; Volume 14; Issue 20; Pages: 5051
Scientia

Subject Terms: dual HER2 targeting, early breast cancer, event-free survival, HER2, pathologic complete response, pertuzumab, trastuzumab, Cancer Research, Oncology, Mama - Càncer - Tractament, Quimioteràpia combinada, Anàlisi de supervivència (Biometria), Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Diagnosis::Prognosis::Treatment Outcome::Disease-Free Survival [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], diagnóstico::pronóstico::resultado del tratamiento::supervivencia sin enfermedad [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS]

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b8cf36fe8d90a0c69dfd272f2b0e29

HTML Full Text     PDF Full Text
9
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer

Authors: N. Harbeck

Source: Breast, Vol 56, Iss, Pp S3-S4 (2021)

Subject Terms: General Medicine, Surgery, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Adjuvant, medicine.medical_treatment, medicine, Internal medicine, medicine.medical_specialty, business.industry, business, Early breast cancer, Oncology

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06050b39e0c21944b6fb19077e0fb04f
https://doi.org/10.1016/j.breast.2022.01.006

11
Delineation of Pathogenomic Insights of Breast Cancer in Young Women

Authors: Paul, Aswathy Mary, George, Bijesh, Saini, Sunil, Pillai, Madhavan Radhakrishna, Toi, Masakazu, Costa, Luis, Kumar, Rakesh

Contributors: Repositório da Universidade de Lisboa

Source: Cells; Volume 11; Issue 12; Pages: 1927

Subject Terms: early breast cancer, genomics, transcriptomics, prognosis, predictive biomarkers, young women, Early breast cancer, Genomics, Predictive biomarkers, Prognosis, Transcriptomics, Young women, General Medicine

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9da95077a8246d8b215f46990ac41de8

HTML Full Text     PDF Full Text
13
South Korean Early Cancer Patients’ Perceptions of Difficulties in Fighting Their Disease: A Q Methodological Approach

Authors: Min-Jeung Shim, Song-Yi Lee

Source: International Journal of Environmental Research and Public Health; Volume 19; Issue 19; Pages: 12510

Subject Terms: early breast cancer, breast cancer patients, difficulties, perception, Q methodology, Health, Toxicology and Mutagenesis, Public Health, Environmental and Occupational Health

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1306371ce2e2d4ec3604359c4ad7d3e2

HTML Full Text     PDF Full Text
15
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Authors: M. Opdam, V. van der Noort, M. Kleijn, A. Glas, I. Mandjes, S. Kleiterp, F. S. Hilbers, D. T. Kruger, A. D. Bins, P. C. de Jong, P. P. J. B. M. Schiphorst, T. van Dalen, B. Flameling, R. C. Rietbroek, A. Beeker, S. M. van den Heiligenberg, S. D. Bakker, A. N. M. Wymenga, I. M. Oving, R. M. Bijlsma, P. J. van Diest, J. B. Vermorken, H. van Tinteren, S. C. Linn

Contributors: Internal medicine, Oncology, AII - Cancer immunology, CCA - Cancer Treatment and Quality of Life, CCA - Cancer biology and immunology

Source: Opdam, M, van der Noort, V, Kleijn, M, Glas, A, Mandjes, I, Kleiterp, S, Hilbers, F S, Kruger, D T, Bins, A D, de Jong, P C, Schiphorst, P P J B M, van Dalen, T, Flameling, B, Rietbroek, R C, Beeker, A, van den Heiligenberg, S M, Bakker, S D, Wymenga, A N M, Oving, I M, Bijlsma, R M, van Diest, P J, Vermorken, J B, van Tinteren, H & Linn, S C 2022, ' Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature ', Breast Cancer Research and Treatment, vol. 194, no. 2, pp. 265-278 . https://doi.org/10.1007/s10549-022-06618-z
Breast Cancer Research and Treatment, 194(2), 265-278. Springer New York
Breast cancer research and treatment
Breast cancer research and treatment, 194(2), 265-278. Springer New York

Subject Terms: Cancer Research, Oncology, Human medicine, Early breast cancer, Endocrine treatment, MammaPrint 70-gene signature, Overtreatment, Postmenopausal, Prognosis

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff14e4330cdee35c7a55ca1f5f2e824
https://research.vumc.nl/en/publications/0eb0b8eb-bf46-4093-94ac-d4d3435e55ac

Search Tools: Get RSS Feed — Email this Search